GlassScriptPhysician profile
Lawrence Pieper
NPI 1184405599
$3,658.67
in general payments reported to CMS, 2019-2025
21 companies · $2,814 in 2025
The $2,814 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $844 · 2025: $2,814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,487 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,486.68 |
| Education | $171.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $825.38 | 2024-2025 | |
| Lilly USA, LLC | $517.02 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Sun Pharmaceutical Industries INC. | $387.30 | 2024-2025 | |
| Janssen Biotech, INC. | $337.21 | 2025 | Tremfya |
| Incyte Corporation | $298.16 | 2024-2025 | Opzelura |
| Ucb, INC. | $279.41 | 2024-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $263.65 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $206.51 | 2024-2025 | Dupixent, Libtayo |
| Verrica Pharmaceuticals INC. | $86.42 | 2024-2025 | Ycanth |
| Arcutis Biotherapeutics, INC. | $81.15 | 2024-2025 | Zoryve |
| Mallinckrodt Hospital Products INC. | $75.67 | 2025 | Acthar |
| Leo Pharma INC. | $50.21 | 2025 | Anzupgo |
| Galderma Laboratories, L.P. | $45.47 | 2025 | Nemluvio |
| Krystal Biotech INC | $41.10 | 2025 | Vyjuvek |
| E.R. Squibb & Sons, L.L.C. | $39.34 | 2025 | Sotyktu |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $31.44 | 2025 | Sofdra |
| Dermavant Sciences, INC. | $20.92 | 2024 | Vtama |
| Pfizer INC. | $20.90 | 2025 | |
| Biofrontera INC. | $19.35 | 2025 | Ameluz |
| Kyowa Kirin, INC. | $18.24 | 2025 | |
| Amgen INC. | $13.82 | 2024 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Pieper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.